Nutrition of patients with pollinosis in the flowering period
This article is devoted to the actual problem of diet prescribing in patients with pollinosis during the flowering period. Pollinosis is an urgent problem of modern therapy. Pollinosis is a pathological condition that occurs during the flowering period of plants and is characterized by the manifestation of signs of allergy. The people the disease was called "hay fever." Recently, the frequency of cases of hay fever has increased, due to poor ecology, low immunity, malnutrition and lack of vitamins and minerals. In patients with pollinosis during the flowering period, the quality of life deteriorates sharply. Patients complain of nasal congestion, frequent sneezing, itchy eyes, swelling of the eyelids, lack of smell, disturbed sleep, headaches. This symptomatology accompanies the patient during the entire pollination of the plant for 2-3 months Diet is a necessary condition for treatment and improvement of the patient's quality of life. The purpose of the study: to study the effectiveness of treatment of pollinosis with and without a Hypo-allergenic diet. Materials and methods: 40 patients with symptoms of pollinosis aged from 20 to 40 years were examined. All of them had symptoms of pollinosis registered in may and June, and all of them had sensitization to birch. All patients were prescribed symptomatic and pathogenetic treatment: inhaled glucocorticosteroids nasonex 1 time per day, mast cell membrane stabilizer-singlon 10mg 1 tablet per day for the period of birch flowering. In addition to treatment, patients in the study group were prescribed a Hypo-allergenic diet with the exception of stone fruits, honey and carrots. Stone fruits (apples, pears, plums, apricots, peaches, cherries, cherries, etc.), honey and carrots have cross sensitization to birch allergens. Accordingly, in addition to treatment, a hypoallergenic diet with the exception of stone fruits, honey and carrots is prescribed to patients of the examined group. Hypoallergenic food was not prescribed to patients of the control group.